Immutep (IMMP) Tax Provisions (2012 - 2024)
Immutep's (IMMP) quarterly Tax Provisions came in at -$14.6 million in Q4 2024, down 5.89% YoY from -$15.6 million in Q1 2024, and up 48.02% on a QoQ basis from -$28.2 million in Q2 2024.
Immutep (IMMP) Tax Provisions (2012 - 2024) Analysis & Trends
Immutep (IMMP) has 8 years of Tax Provisions data on file, last reported at -$14.6 million in Q4 2024.
- Quarterly Tax Provisions fell 5.89% year-over-year to -$14.6 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$70.2 million (down 62.07% YoY) and the FY2022 annual result came in at $24.35, down 4.17% from the prior year.
- Tax Provisions climbed to -$14.6 million in Q4 2024, from -$28.2 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of -$11.9 million in Q4 2021 to a low of -$28.2 million in Q2 2024.
- A 4-year average of -$16.4 million and a median of -$13.8 million in 2023 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions declined 14.32% — and 2023, when it retreated 1.99%.
- Tracing IMMP's Tax Provisions over 4 years: stood at -$11.9 million in 2021, then slipped by 14.32% to -$13.5 million in 2022, then decreased by 1.99% to -$13.8 million in 2023, then dropped by 5.89% to -$14.6 million in 2024.
- The last three Tax Provisions figures came in at -$14.6 million (Q4 2024), -$28.2 million (Q2 2024), and -$13.8 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.31 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.90 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -90.33 Mn |
| 10 | Immutep | 57.14 Mn | -7.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -14.63 Mn |
| Jun 30, 2024 | -28.15 Mn |
| Dec 31, 2023 | -13.82 Mn |
| Dec 31, 2022 | -13.55 Mn |
| Dec 31, 2021 | -11.85 Mn |
| Dec 31, 2019 | -4.07 Mn |
| Jun 30, 2019 | -12.85 Mn |
| Dec 31, 2018 | -6.23 Mn |
| Dec 31, 2016 | -3.05 Mn |
| Dec 31, 2012 | -8.34 Mn |